|
|
Article: Novartis says Indian Patents Act violated TRIPS.
- Article from:
- PTI - The Press Trust of India Ltd.
- Article date:
- March 5, 2007
CopyrightCOPYRIGHT 2007 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Novartis says Indian Patents Act violated TRIPS
Chennai, Mar 5 (PTI) Switzerland-based pharmaceutical major Novartis AG today contended before the Madras High Court that the Centre's amendment to the Indian Patents Act "violated" the TRIPS agreement.
It told a division bench of Justices R Balasubramanian and Prabha Sridevan that its application for patenting the beta crystalline form of Imatinib Mesylate was rejected under section 3(d) of the Act.
Senior Supreme Court counsel Shanthi Bushan who appeared on behalf of Novartis said the impugned section 3(d) of the Patents Act took away the right given under the Trade Related Aspects of ...